We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-3.84%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$6.16B
AUM Growth
+$1.7B
Cap. Flow
+$2.17B
Cap. Flow %
35.15%
Top 10 Hldgs %
26.62%
Holding
7,028
New
630
Increased
3,221
Reduced
2,151
Closed
574

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$204M
2
MSFT icon
Microsoft
MSFT
+$195M
3
AMZN icon
Amazon
AMZN
+$97.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$95M
5
TSM icon
TSMC
TSM
+$69.5M

Sector Composition

Rank Sector Weight
1 Technology 26.99%
2 Healthcare 10.86%
3 Consumer Discretionary 10.71%
4 Financials 8.62%
5 Communication Services 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOFO
4601
DELISTED
Sonic Foundry, Inc. Common Stock
SOFO
$10K ﹤0.01%
8,003
+454
+6% +$702
CCVI.U
4602
DELISTED
Churchill Capital Corp VI Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
CCVI.U
$10K ﹤0.01%
997
NEWR
4603
DELISTED
New Relic, Inc.
NEWR
$10K ﹤0.01%
182
-143
-44% -$8.58K
NVOS
4604
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$10K ﹤0.01%
981
+606
+162% +$9.85K
AAC.U
4605
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$10K ﹤0.01%
992
BRDS
4606
DELISTED
Bird Global, Inc.
BRDS
$10K ﹤0.01%
1,125
+262
+30% +$3.1K
PRTK
4607
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$10K ﹤0.01%
3,768
+2,443
+184% +$6.08K
ZEV
4608
DELISTED
Lightning eMotors, Inc.
ZEV
$10K ﹤0.01%
314
-39
-11% -$2.22K
PRDS
4609
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$10K ﹤0.01%
5,648
-2,099
-27% -$6.26K
MOBQ
4610
DELISTED
Mobiquity Technologies, Inc. Common Stock
MOBQ
$10K ﹤0.01%
598
+295
+97% +$6.44K
WLMS
4611
DELISTED
Williams Industrial Services Group Inc.
WLMS
$10K ﹤0.01%
7,190
+2,820
+65% +$4.21K
ARDS
4612
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$10K ﹤0.01%
10,669
+2,592
+32% +$4.03K
DOMA
4613
DELISTED
Doma Holdings, Inc.
DOMA
$10K ﹤0.01%
880
-62
-7% -$1.11K
TRKA
4614
DELISTED
Troika Media Group, Inc. Common Stock
TRKA
$10K ﹤0.01%
1,151
+507
+79% +$8.22K
EUCR
4615
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
$10K ﹤0.01%
987
-2
-0.2% -$20
GLS
4616
DELISTED
Gelesis Holdings, Inc.
GLS
$10K ﹤0.01%
8,955
+7,070
+375% +$9.36K
BOXD
4617
DELISTED
Boxed, Inc.
BOXD
$10K ﹤0.01%
10,861
-14,803
-58% -$21.6K
PONOU
4618
DELISTED
Pono Capital Corp Unit
PONOU
$10K ﹤0.01%
1,000
GIIX
4619
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
$10K ﹤0.01%
1,025
-885
-46% -$8.73K
GLHA
4620
DELISTED
Glass Houses Acquisition Corp. Class A common stock
GLHA
$10K ﹤0.01%
1,057
-29
-3% -$284
ENPC
4621
DELISTED
Executive Network Partnering Corporation
ENPC
$10K ﹤0.01%
1,017
-1,412
-58% -$14K
ZY
4622
DELISTED
Zymergen Inc. Common Stock
ZY
$10K ﹤0.01%
3,778
-18,754
-83% -$45.5K
CORS.U
4623
DELISTED
Corsair Partnering Corporation Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CORS.U
$10K ﹤0.01%
972
PLM
4624
DELISTED
PolyMet Mining Corp.
PLM
$10K ﹤0.01%
3,599
-7,773
-68% -$23.2K
ACHV icon
4625
Achieve Life Sciences
ACHV
$744M
$9K ﹤0.01%
2,676
-217
-8% -$1.04K

Similar funds

Tower Research Capital (TRC)'s Q3 2022 Portfolio in Review

As of Q3 2022, Tower Research Capital (TRC) held 7,028 positions worth $6.16B, up 38% from $4.46B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $2.17B of net new capital in Q3 2022, opening 630 new positions and adding to 3,221 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $53M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2022 buy was iShares Core S&P Mid-Cap ETF: 347,965 shares worth $15.3M.
  • Tower Research Capital (TRC) added most to Apple in Q3 2022, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $53M.
  • Tower Research Capital (TRC) fully exited State Street SPDR Portfolio S&P 500 ETF in Q3 2022, selling an estimated $6.39M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $6.16B portfolio in Q3 2022.
  • Tower Research Capital (TRC) opened 630 new positions and closed 574 in Q3 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 38% quarter-over-quarter to $6.16B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2022, filed 10 Nov 2022.